The rise of Cell and Gene Therapies (CGT) marks a significant advancement in modern medicine, offering […]
Japan’s IVD market presents a significant opportunity for international companies expanding into Asia. The advanced healthcare […]
The medical device industry demands the highest standards of quality and safety for its poducts. ISO […]
Overview: Introduction Six-month review process priority registration expanded PMDA support innovative drug consultation early application feedback […]
Japanese Market Opportunities in AI-Driven Elderly Care: Living, Health, and Medication Management The silver economy of […]
A Thriving Landscape in Japan’s Pharma Sector Pharma Japan and Strategic Opportunities are plentiful in Japan. […]
Japan’s Bioeconomy Strategy 2030 marks a transformative approach to integrating biotechnology into Japan’s economic fabric. It’s […]
Once a flourishing beacon of innovation and global leadership, Japan’s pharmaceutical industry has encountered significant headwinds […]